Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-09

FDA Approved: METHOCARBAMOL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for methocarbamol from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOCARBAMOL (Methocarbamol)

Snippet

SUPPL AP for METHOCARBAMOL (METHOCARBAMOL)